University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Post COVID-19 Biorepository

Recruiting

Conditions: Coronavirus Infection

First Posted Date: 2021-05-13

Last Posted Date: 2024-08-21

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 100

Registration Number: NCT04885504

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Use of CBT-I in Individuals With a Concussion

Not Applicable

Completed

Conditions: Concussion, Mild

Interventions: Behavioral: cognitive behavioral therapy for insomnia (CBT-I)

First Posted Date: 2021-05-13

Last Posted Date: 2023-03-17

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 40

Registration Number: NCT04885205

Locations: 🇺🇸
Catherine Siengsukon, Kansas City, Kansas, United States

Preventing Excessive Weight Gain and Maternal and Infant Fat Accretion

Not Applicable

Active, not recruiting

Conditions: Gestational Weight Gain
Infant Fat Accretion
Maternal Fat Accretion

Interventions: Behavioral: High fiber diet

First Posted Date: 2021-04-30

Last Posted Date: 2023-06-05

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 56

Registration Number: NCT04868110

Locations: 🇺🇸
The University of Kansas Medical Center, Kansas City, Kansas, United States

Combined Exercise Trial

Not Applicable

Recruiting

Conditions: Healthy Aging

Interventions: Behavioral: Exercise

First Posted Date: 2021-04-19

Last Posted Date: 2024-10-10

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 280

Registration Number: NCT04848038

Locations: 🇺🇸
University of Kansas Alzheimer's Disease Center, Fairway, Kansas, United States

Reversing Glucose and Lipid-mediated Vascular Dysfunction

Early Phase 1

Recruiting

Conditions: Hypertension
Blood Pressure

Interventions: Drug: Dextrose 20 % in 500 ML Injection
Drug: Intralipid
Drug: Saline
Drug: Ascorbic acid

First Posted Date: 2021-04-05

Last Posted Date: 2024-10-08

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 46

Registration Number: NCT04832009

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

Completed

Conditions: BPH
Benign Prostatic Hyperplasia

Interventions: Other: Standard of Care (Holmium Laser)
Other: SOLTIVE Thulium Laser

First Posted Date: 2021-04-01

Last Posted Date: 2024-10-02

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 15

Registration Number: NCT04826887

Locations: 🇺🇸
University of Kansas Medcial Center, Kansas City, Kansas, United States

To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment

Active, not recruiting

Conditions: Breast Cancer
Melanoma (Skin)
Lung Cancer

Interventions: Biological: COVID-19 Vaccine

First Posted Date: 2021-03-29

Last Posted Date: 2023-04-04

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 500

Registration Number: NCT04821570

Locations: 🇺🇸
The University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Phase 2

Recruiting

Conditions: Risk Reduction
Breast Cancer

Interventions: Drug: Bazedoxifene and Conjugated Estrogens

First Posted Date: 2021-03-29

Last Posted Date: 2024-12-18

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 120

Registration Number: NCT04821141

Locations: 🇺🇸
Northwestern Medical Center, Chicago, Illinois, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
City of Hope Medical Center, Duarte, California, United States

and more 2 locations

Pulmonary Hypertension Biorepository and Registry

Recruiting

Conditions: Pulmonary Hypertension, Primary
Pulmonary Hypertension, Primary, 3
Pulmonary Hypertension
Chronic Thromboembolic Pulmonary Hypertension
Pulmonary Arterial Hypertension
Pulmonary Hypertension, Primary, 4
Pulmonary Hypertension, Primary, 2
Pulmonary Hypertension Due to Left Heart Disease
Pulmonary Hypertension Due to Lung Diseases and Hypoxia

First Posted Date: 2021-03-22

Last Posted Date: 2024-08-21

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 300

Registration Number: NCT04808596

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density

Completed

Conditions: Opioid Use
Nerve Disorders
Chronic Pain

First Posted Date: 2021-03-17

Last Posted Date: 2024-11-06

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 38

Registration Number: NCT04801498

Locations: 🇺🇸
University of Kansas Health System, Kansas City, Kansas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy